Alvotech (ALVO) Long-Term Investments (2020 - 2024)
Alvotech (ALVO) posted Long-Term Investments of $18.5 million for Q1 2024, little changed on a QoQ basis from $18.5 million in Q4 2023, and down 61.14% year-over-year from $47.6 million in Q2 2023.
Alvotech (ALVO) Long-Term Investments (2020 - 2024) Analysis & Trends
Alvotech's Long-Term Investments history runs 5 years deep, the most recent figure standing at $18.5 million for Q1 2024.
- Quarterly Long-Term Investments fell 61.14% year-over-year to $18.5 million in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $18.5 million (down 61.14% YoY) and the FY2023 annual result came in at $18.5 million, down 61.92% from the prior year.
- Long-Term Investments was $18.5 million for Q1 2024 at Alvotech, roughly flat from $18.5 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $56.7 million in Q4 2020 and bottomed at $18.5 million in Q4 2023.
- A 5-year average of $42.5 million and a median of $48.1 million in 2022 frame the typical range for Long-Term Investments.
- Annual changes were most pronounced in 2021 — Long-Term Investments slipped 2.42% — and 2023, when it slumped 61.92%.
- Alvotech's Long-Term Investments stood at $56.7 million in 2020, then fell by 2.42% to $55.3 million in 2021, then retreated by 12.18% to $48.6 million in 2022, then sank by 61.92% to $18.5 million in 2023, then changed by 0.0% to $18.5 million in 2024.
- Business Quant data shows ALVO's Long-Term Investments at $18.5 million in Q1 2024, $18.5 million in Q4 2023, and $43.6 million in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 56.09 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.32 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 702.35 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 146.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Alvotech | 935.87 Mn | 935.87 Mn | 5.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 18.49 Mn |
| Dec 31, 2023 | 18.49 Mn |
| Jun 30, 2023 | 43.61 Mn |
| Mar 31, 2023 | 47.59 Mn |
| Dec 31, 2022 | 48.57 Mn |
| Jun 30, 2022 | 51.33 Mn |
| Dec 31, 2021 | 55.31 Mn |
| Dec 31, 2020 | 56.68 Mn |